SRNE

Sorrento Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.725 -7.52% 8.915 11:44:04
Open Price Low Price High Price Close Price Prev Close
9.51 8.76 9.70 9.64
more quote information »

Recent News

Date Time Source Heading
1/19/202117:05GLOBESorrento to Present Data Demonstrating STI-2020 Preserves..
1/19/202102:05GLOBEDr. Henry Ji to Participate in a Fireside Chat at the B...
1/14/202120:31TRMNSorrento Stock Could Hit $30, Says Analyst
1/11/202106:05EDGARCurrent Report Filing (8-k)
1/10/202117:58GLOBEDr. Henry Ji to Participate in the H.C. Wainwright..
12/30/202012:47GLOBESorrento Announces the Submission of a Marketing..
12/23/202008:24TRMNSorrento Pops 8% Pre-Market On FDA Application For Covid-19..
12/23/202006:04EDGARCurrent Report Filing (8-k)
12/22/202018:59GLOBESorrento Announces It Has Submitted An Emergency Use..
12/15/202017:26EDGARCurrent Report Filing (8-k)
12/09/202009:01EDGARCurrent Report Filing (8-k)
12/09/202009:00GLOBESorrento Receives US FDA Clearance to Proceed With Phase 1..
12/08/202020:05GLOBESorrento Receives Licensure From the State of California for..
12/04/202017:16EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/04/202017:11EDGARCurrent Report Filing (8-k)
12/04/202017:06EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/29/202020:19GLOBESorrento to Participate in the 32nd Piper Sandler Healthcare..
11/27/202008:00EDGARCurrent Report Filing (8-k)
11/27/202008:00GLOBEDARPA and JPEO Award Contract to SmartPharm, a Subsidiary of..
11/17/202006:05EDGARCurrent Report Filing (8-k)
11/11/202009:00GLOBESorrento Announces IND Filing for COVI-DROPS, an Intranasal..
11/09/202009:00GLOBESorrento Announces FDA IND Filing Today for COVI-AMG..
11/09/202006:02EDGARQuarterly Report (10-q)
10/29/202009:01EDGARCurrent Report Filing (8-k)
10/29/202009:00GLOBESorrento Announces That Intranasal Administration of..
10/22/202017:26EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/22/202017:26EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/21/202016:17EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/21/202006:05EDGARNotice of Effectiveness (effect)
10/20/202017:22EDGARCurrent Report Filing (8-k)
10/20/202009:01EDGARStatement of Changes in Beneficial Ownership (4)
10/16/202016:31EDGARCurrent Report Filing (8-k)
10/14/202011:56GLOBEBrazilian Health Regulatory Agency (ANVISA) Authorizes..
10/13/202006:04EDGARCurrent Report Filing (8-k)
10/12/202017:20GLOBESorrento Adds Mesenchymal Stem Cell Program (MSC) That Has..
10/09/202019:46GLOBESorrento COVID-19 R&D October 13, 2020 Pipeline Call Details..
10/09/202013:09EDGARCurrent Report Filing (8-k)
10/08/202017:23EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/08/202016:16EDGARSecurities Registration Statement (simplified Form) (s-3)
10/07/202015:09GLOBESorrento Announces the Discovery of Salicyn-30 Small..
10/07/202006:00GLOBEScilex Holding Company, a Subsidiary of Sorrento..
10/04/202018:39GLOBESorrento to Host a R&D Day to Showcase COVID-19 Product..
10/02/202016:16EDGARCurrent Report Filing (8-k)
9/30/202017:22EDGARSecurities Registration Statement (simplified Form) (s-3)
9/30/202009:26GLOBESORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO..
9/30/202009:00GLOBESorrento Therapeutics and ViralClear Enter Into Agreement to..
9/29/202006:08EDGARCurrent Report Filing (8-k)
9/28/202023:59GLOBESorrento Releases Preclinical Data for STI-1499..
9/28/202016:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/28/202009:00GLOBESorrento Releases Positive Results of Phase 1B Trial of..
See more news about this stock »
Your Recent History
NASDAQ
SRNE
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210125 16:59:05